Surmodics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
SRDX Nasdaq 2836 www.surmodics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Surmodics, Inc.

SurModics (SRDX) Loses -13.87% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Feb 3rd, 2025 2:35 pm
Surmodics Announces Successful Early Clinical Use of Pounce™ XL Thrombectomy System, Suitable for Non-Surgical Removal of Thrombi and Emboli from Iliac and Femoral Arteries - Feb 3rd, 2025 12:00 pm
Surmodics Stock Down Despite Q1 Earnings Beat, Gross Margin Up - Jan 31st, 2025 4:16 pm
Compared to Estimates, SurModics (SRDX) Q1 Earnings: A Look at Key Metrics - Jan 30th, 2025 2:30 pm
SurModics (SRDX) Reports Q1 Loss, Misses Revenue Estimates - Jan 30th, 2025 1:20 pm
SurModics: Fiscal Q1 Earnings Snapshot - Jan 30th, 2025 12:24 pm
Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results - Jan 30th, 2025 12:00 pm
Here's Why You Should Add Surmodics Stock to Your Portfolio Now - Jan 23rd, 2025 12:25 pm
After Plunging -10.42% in 4 Weeks, Here's Why the Trend Might Reverse for SurModics (SRDX) - Jan 14th, 2025 2:35 pm
SurModics (SRDX) Upgraded to Strong Buy: What Does It Mean for the Stock? - Jan 3rd, 2025 5:00 pm
Best Momentum Stocks to Buy for January 3rd - Jan 3rd, 2025 3:00 pm
Why Is SurModics (SRDX) Up 4% Since Last Earnings Report? - Dec 6th, 2024 4:31 pm
SurModics Inc. Faces Legal Hurdles: Shareholder Lawsuits Threaten Merger and Financial Stability - Nov 22nd, 2024 6:01 am
SurModics (SRDX) is an Incredible Growth Stock: 3 Reasons Why - Nov 12th, 2024 5:45 pm
Surmodics Q4 Earnings and Revenues Beat Estimates, Margin Down - Nov 7th, 2024 3:07 pm
SurModics (SRDX) Reports Q4 Loss, Tops Revenue Estimates - Nov 6th, 2024 1:20 pm
SurModics: Fiscal Q4 Earnings Snapshot - Nov 6th, 2024 12:28 pm
Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results - Nov 6th, 2024 12:00 pm
Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System - Oct 30th, 2024 6:30 pm
SRDX Stock Down Despite FDA Clearance for Pounce XL System - Oct 2nd, 2024 2:34 pm